Germitec’s €11 Million Financing Round

Goodwin advised Germitec on the deal.

Germitec, a global healthcare leader in high-Level UV-C disinfection systems, announced the financing round of €11 million.

Reference investors in the healthcare sector, Financière Arbevel, Kurma Partners, via its Kurma Growth Opportunities fund, and Sham Innovation Santé advised by Turenne Capital, become GERMITEC shareholders. Private investors and Southwest regional funds (Aquiti Gestion, via its NACO fund, and Galia Gestion) also join this financing round.

The main objective of this new financing round is to launch an ambitious international commercial expansion plan.

The Goodwin team was led by Anne-Charlotte Rivière (Picture) and included Aude Steinberg on corporate aspects, Marie Fillon and Louis de Chezelles on IP aspects, as well as Marie-Laure Bruneel on tax aspects.

Involved fees earner: Marie-Laure Bruneel – Goodwin Procter; Louis de Chezelles – Goodwin Procter; Marie Fillon – Goodwin Procter; Anne-Charlotte Rivière – Goodwin Procter; Aude Steinberg – Goodwin Procter;

Law Firms: Goodwin Procter;

Clients: Germitec S.A.;

Martina Bellini

Author: Martina Bellini